Filter
669
Text search:
K.
Hill
Featured
63
155
Language
Document type
376
125
106
31
15
7
6
2
1
Countries / Regions
30
24
18
14
14
13
13
12
11
10
9
8
8
8
8
8
7
7
6
6
6
6
6
5
5
5
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
215
75
44
41
20
10
8
1
Toolboxes
69
61
48
42
26
25
17
16
15
15
14
12
11
7
7
5
5
5
5
4
3
2
2
1
1
Guidelines for treatment of drug-susceptible tuberculosisand patient care
2017 Update
MMWR. Recommendations and Reports:
December 16, 2005 / 54(RR15);49-55
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan
...
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
Key populations brief
Accessed 2017
Rapport sur les populations clès
Accessed November 2017
Informe sobre poblaciones clave
Key populations brief.
Key populations brief.
Mapping Report - Ireland.
NOVEMBER 2012
This document serves as an update to “Out of the Dark”, a report published by MSF in October 2011, highlighting the need to prioritise the long-neglected area of paediatric tuberculosis (TB). This update will outline the key improvements and setbacks—the ‘highlights’ and ‘
...
Joining efforts to control two trelated global epidemics.
